108 related articles for article (PubMed ID: 21844471)
1. Lymphomatoid drug reaction to ustekinumab.
Jung J; Levin EC; Jarrett R; Lu D; Mann C
Arch Dermatol; 2011 Aug; 147(8):992-3. PubMed ID: 21844471
[No Abstract] [Full Text] [Related]
2. Eczematous drug eruption after ustekinumab treatment.
Pernet C; Guillot B; Bessis D
Arch Dermatol; 2012 Aug; 148(8):959-60. PubMed ID: 22911203
[No Abstract] [Full Text] [Related]
3. Flare of pustular psoriasis after initiating ustekinumab therapy.
Wenk KS; Claros JM; Ehrlich A
J Dermatolog Treat; 2012 Jun; 23(3):212-4. PubMed ID: 21254881
[TBL] [Abstract][Full Text] [Related]
4. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
[No Abstract] [Full Text] [Related]
5. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
6. [Patient education. Information letter on treatment of psoriasis with ustekinumab (Stelara)].
Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
Ann Dermatol Venereol; 2011 Dec; 138(12):874-5. PubMed ID: 22137636
[No Abstract] [Full Text] [Related]
7. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
Mielke F; Schneider-Obermeyer J; Dörner T
Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
[No Abstract] [Full Text] [Related]
8. Lymphomatoid papulosis while on efalizumab.
Leo AM; Ermolovich T
J Am Acad Dermatol; 2009 Sep; 61(3):540-1. PubMed ID: 19700027
[No Abstract] [Full Text] [Related]
9. Urticarial vasculitis due do infliximab.
Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
[No Abstract] [Full Text] [Related]
10. Adverse skin reaction to Secukinumab.
Peigottu MF; Montesu MA
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e432-e433. PubMed ID: 28370441
[No Abstract] [Full Text] [Related]
11. Reply to a letter from Dr Drago.
Ohtsuka T
J Dermatol; 2014 Sep; 41(9):865-566. PubMed ID: 25182299
[No Abstract] [Full Text] [Related]
12. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
13. Secukinumab-Induced Psoriasiform Eruption.
Sladden MJ; Sladden CS; Gulliver WPF
JAMA Dermatol; 2017 Nov; 153(11):1194-1195. PubMed ID: 28768308
[No Abstract] [Full Text] [Related]
14. Pityriasis rosea and pityriasis rosea-like eruption: can they be distinguished?
Drago F; Ciccarese G; Rebora A; Parodi A
J Dermatol; 2014 Sep; 41(9):864-5. PubMed ID: 25182298
[No Abstract] [Full Text] [Related]
15. Psoriasiform and pustular eruption induced by etanercept and infliximab.
Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
[No Abstract] [Full Text] [Related]
16. Brodalumab-induced palmar pustular eruption and joint swelling accompanied by muscle pains in two cases of psoriasis.
Takahashi H; Sato K; Takagi A; Iizuka H
J Dermatol; 2018 Nov; 45(11):e325-e326. PubMed ID: 29767849
[No Abstract] [Full Text] [Related]
17. Recurrent angular cheilitis after secukinumab injections.
Hitaka T; Sawada Y; Okada E; Nakamura M
Australas J Dermatol; 2018 Feb; 59(1):e79-e80. PubMed ID: 28620989
[No Abstract] [Full Text] [Related]
18. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
19. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?
Michaëlsson G; Kajermo U; Michaëlsson A; Hagforsen E
Br J Dermatol; 2005 Dec; 153(6):1243-4. PubMed ID: 16307676
[No Abstract] [Full Text] [Related]
20. Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials.
Gordon KB; Papp KA; Langley RG; Ho V; Kimball AB; Guzzo C; Yeilding N; Szapary PO; Fakharzadeh S; Li S; Hsu MC; Reich K
J Am Acad Dermatol; 2012 May; 66(5):742-51. PubMed ID: 21978572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
